Calculate your body mass index (BMI)

Weight

Feet

Inches

Your BMI

Back to list

Healthy Volunteer 244192


Study Dates:

Cohort 5:Screen: Jun 19 In-house stay Jun 23 - Jul 2 follow-up Jul 09

Study Number

244192

Group

●  Postmenopausal
●  Smoking (No)
●  Non-Childbearing Females

Compensation

Up to: $4,000

Gender

Male, Female, Non-Smoker

Age

18-55

BMI

18-32

Details

This study involves 1 screening visit one in-house stay of 10 days / 9 nights and 1 follow up visit

The study is to assess the bioavailability of Gilteritinib following a single dose of ASP2215 Oral Suspension and ASP 2215 mini-tablets compared to a single dose of 40mg Gilteritinib

Females must be either Postmenopausal for at least 12 months or have documented hysterectomy,bilateral salpingectomy or bilateral opphorectomy